Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
CGCarlos G. Santos‐GallegoAPAriana P. Vargas-DelgadoJAJuan Antonio Requena-IbáñezÁGÁlvaro García‐RoperoDMDonna Mancini
Mount Sinai Hospital · Mount Sinai Hospital · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
517
total citations
- FWCI
- 41.15
- Percentile
- 100%
- References
- 45
Citations per year
Authors
23- CGCarlos G. Santos‐GallegoCorresponding
Mount Sinai Hospital, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
- APAriana P. Vargas-Delgado
Mount Sinai Hospital, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
- JAJuan Antonio Requena-Ibáñez
Mount Sinai Hospital, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
- ÁGÁlvaro García‐Ropero
Mount Sinai Hospital, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
- DMDonna Mancini
Mount Sinai Hospital
Topics & keywords
Topics
Keywords
- Empagliflozin
- Ejection fraction
- Medicine
- Cardiology
- Placebo
- Heart failure
- Internal medicine
- Clinical endpoint
No related works found for this paper.